Login / Signup

Plasma proteomic and metabolomic signatures of B-ALL patients during CAR-T cell therapy.

Jianghua WuLu TangMengyi DuChenggong LiHaiming KouHuiwen JiangWenjing LuoYinqiang ZhangZhongpei HuangDanying LiaoWei XiongHeng MeiYu Hu
Published in: Clinical and translational medicine (2023)
Keyphrases
  • cell therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • stem cells
  • genome wide